Abstract:Purpose The purpose of this study is to analyze clinical information and combine significant parameters to generate a predictive model and achieve a better prognosis prediction of dermatomyositis-associated interstitial lung disease with positive melanoma differentiation-associated gene 5 antibody (MDA5 + DM-ILD) and stratify patients according to prognostic risk factors appropriately. Methods We retrospectively reviewed 63 patients MDA5 + DM-ILD who were treated in our hospital from January 2018 to January 2021. Our study incorporated most clinical characteristics in clinical practice to explore the associations and predictive functions of clinical characteristics and prognosis. Student's t -test, Mann-Whitney U -test, chi-squared test, Pearson correlation analysis, Cox regression analysis, R, receiver operating characteristic curves (ROC curves), and Kaplan-Meier survival curves were performed to identify independent predictors for the prognosis of MDA5 + DM-ILD. Results In all the 63 patients with MDA5 + DM-ILD, 44 improved but 19 did not. Poor prognosis was found more frequently in patients who were older, clinically amyopathic variant of dermatomyositis (CADM), and/or with short duration, short interval of DM and ILD, long length of stay, fever, dyspnea, non-arthralgia, pulmonary infection, pleural effusion (PE), high total computed tomography scores (TCTs), ground-glass opacity (GGO), consolidation score, reticular score and fibrosis score, decreased forced vital capacity (FVC), forced expiratory volume in 1s (FEV1), albumin, A/G, glomerular filtration rate (GFR) and tumor necrosis factor α (TNFα), high titer of anti-MDA5, proteinuria, high levels of monocyte, lactate dehydrogenase (LDH), ferritin (FER), neuron specific enolase (NSE) and glucocorticoid, antibiotic, antiviral, and non-invasive positive pressure ventilation (NPPV). The multivariate Cox regression analysis demonstrated that duration, fever, PE, TCTs and aspartate transaminase (AST) were independent predictors of poor prognosis in patients with MDA5 + DM-ILD. The nomogram model quantified the risk of 400-day death as: duration ≤ 4 months (5 points), fever (88 points), PE (21 points), TCTs ≥10 points (22 points), and AST ≥200 U/L (100 points) with high predictive accuracy and convenience. The ROC curves possessed good discriminative ability for combination of fever, PE, TCTs, and AST, as reflected by the area under curve (AUC) being.954, 95% CI 0.902–1.000, and sensitivity and specificity being 84.2 and 94.6%, respectively. Conclusion We demonstrated that duration, fever, PE, TCTs, and AST could be integrated together to be independent predictors of poor prognosis in MDA5 + DM-ILD with highly predictive accuracy.

ILD-GAP combined with the monocyte ratio could be a better prognostic prediction model than ILD-GAP in patients with interstitial lung diseases

Predicting Survival Across Acute Exacerbation of Interstitial Lung Disease in Patients with Idiopathic Inflammatory Myositis: the GAP-ILD Model

The Lungs Were on Fire: a Pilot Study of 18F-FDG PET/CT in Idiopathic-Inflammatory-myopathy-related Interstitial Lung Disease

The Interstitial Lung Disease-Gender-Age-Physiology Index Can Predict the Prognosis in Surgically Resected Patients with Interstitial Lung Disease and Concomitant Lung Cancer

A composite score based on cardiovascular parameters can predict the mortality risk of patients with newly diagnosed interstitial lung disease: A prospective observational study

Risk assessment in interstitial lung disease: the incremental prognostic value of cardiopulmonary ultrasound

Interleukin-6 and Granulocyte Colony-Stimulating Factor As Predictors of the Prognosis of Influenza-Associated Pneumonia

Prediction of long-term mortality by using machine learning models in Chinese patients with connective tissue disease-associated interstitial lung disease

Multidisciplinary-derived clinical score for accurate prediction of long-term mortality in fibrotic lung disease patients

External validation of the GAP model in Chinese patients with idiopathic pulmonary fibrosis

Blood monocyte counts as a prognostic biomarker and predictor in Chinese patients with idiopathic pulmonary fibrosis

A nomogram model combining computed tomography-based radiomics and Krebs von den Lungen-6 for identifying low-risk rheumatoid arthritis-associated interstitial lung disease

A New Predictive Model for the Prognosis of MDA5+ DM-ILD

Modified blood cell GAP model as a prognostic biomarker in idiopathic pulmonary fibrosis

Impact of interstitial lung disease gender-age-physiology index in surgically treated lung cancer

Peripheral blood monocyte count and outcomes in patients with interstitial lung disease: a systematic review and meta-analysis

A meta-analysis of the clinical significance of neutrophil-to-lymphocyte ratios in interstitial lung disease

Impact of GAP score on surgical prognosis of non-small-cell lung cancer with usual interstitial pneumonia

Development of a scoring system with multidimensional markers for fibrosing interstitial lung disease

Pretreatment mortality risk prediction model in patients with polymyositis/dermatomyositis-associated interstitial lung disease